Detalhe da pesquisa
1.
Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 109(17): 6668-73, 2012 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22493267
2.
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Blood
; 120(2): 249-58, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22529287
3.
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.
Blood
; 119(10): 2314-24, 2012 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22251480
4.
The prognostic and functional role of microRNAs in acute myeloid leukemia.
Blood
; 117(4): 1121-9, 2011 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21045193
5.
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Blood
; 118(15): 4188-98, 2011 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21828125
6.
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Blood
; 118(26): 6920-9, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031865
7.
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(5): 788-92, 2010 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20442368
8.
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(18): 3622-6, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20656931
9.
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(25): 5660-9, 2010 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20841507
10.
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
N Engl J Med
; 358(18): 1919-28, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18450603
11.
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Haematologica
; 96(10): 1488-95, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21659357
12.
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
Blood
; 111(11): 5371-9, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18378853
13.
Molecular signatures in acute myeloid leukemia.
Curr Opin Hematol
; 16(2): 64-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19468266
14.
Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.
Clin Cancer Res
; 14(18): 5900-6, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18794103
15.
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
J Clin Oncol
; 23(36): 9234-42, 2005 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16275934
16.
Oxygen limitation modulates pH regulation of catabolism and hydrogenases, multidrug transporters, and envelope composition in Escherichia coli K-12.
BMC Microbiol
; 6: 89, 2006 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-17026754
17.
A paradigm for class prediction using gene expression profiles.
J Comput Biol
; 9(3): 505-11, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12162889
18.
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.
J Clin Oncol
; 31(9): 1172-81, 2013 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23382473
19.
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
J Clin Oncol
; 30(7): 742-50, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22291079
20.
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
J Clin Oncol
; 30(25): 3109-18, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22753902